36711847|t|Circulating Endothelial Progenitor Cells Reduce the Risk of Alzheimer's Disease.
36711847|a|Cerebrovascular damage coexists with Alzheimer's disease (AD) pathology and increases AD risk. However, it is unclear whether endothelial progenitor cells reduce AD risk via cerebrovascular repair. By using the Framingham Heart Study (FHS) offspring cohort, which includes data on different progenitor cells, the incidence of AD dementia, peripheral and cerebrovascular pathologies, and genetic data (n = 1,566), we found that elevated numbers of circulating endothelial progenitor cells with CD34+CD133+ co-expressions had a dose-dependent association with decreased AD risk (HR = 0.67, 95% CI: 0.46-0.96, p = 0.03) after adjusting for age, sex, years of education, and APOE epsilon4. With stratification, this relationship was only significant among those individuals who had vascular pathologies, especially hypertension (HTN) and cerebral microbleeds (CMB), but not among those individuals who had neither peripheral nor central vascular pathologies. We applied a genome-wide association study (GWAS) and found that the number of CD34+CD133+ cells impacted AD risk depending on the homozygous genotypes of two genes: KIRREL3 rs580382 CC carriers (HR = 0.31, 95% CI: 0.17-0.57, p<0.001), KIRREL3 rs4144611 TT carriers (HR = 0.29, 95% CI: 0.15-0.57, p<0.001), and EXOC6B rs61619102 CC carriers (HR = 0.49, 95% CI: 0.31-0.75, p<0.001) after adjusting for confounders. In contrast, the relationship did not exist in their counterpart genotypes, e.g. KIRREL3 TT/CT or GG/GT carriers and EXOC6B GG/GC carriers. Our findings suggest that circulating CD34+CD133+ endothelial progenitor cells can be therapeutic in reducing AD risk in the presence of cerebrovascular pathology, especially in KIRREL3 and EXOC6B genotype carriers.
36711847	60	79	Alzheimer's Disease	Disease	MESH:D000544
36711847	81	103	Cerebrovascular damage	Disease	MESH:D002561
36711847	118	137	Alzheimer's disease	Disease	MESH:D000544
36711847	139	141	AD	Disease	MESH:D000544
36711847	167	169	AD	Disease	MESH:D000544
36711847	243	245	AD	Disease	MESH:D000544
36711847	407	418	AD dementia	Disease	MESH:D000544
36711847	574	578	CD34	Gene	947
36711847	579	584	CD133	Gene	8842
36711847	649	651	AD	Disease	MESH:D000544
36711847	752	756	APOE	Gene	348
36711847	859	867	vascular	Disease	MESH:D057772
36711847	892	904	hypertension	Disease	MESH:D006973
36711847	906	909	HTN	Disease	MESH:D006973
36711847	915	935	cerebral microbleeds	Disease	MESH:D002547
36711847	937	940	CMB	Disease	MESH:D002547
36711847	1014	1022	vascular	Disease	MESH:D057772
36711847	1115	1119	CD34	Gene	947
36711847	1120	1125	CD133	Gene	8842
36711847	1142	1144	AD	Disease	MESH:D000544
36711847	1202	1209	KIRREL3	Gene	84623
36711847	1210	1218	rs580382	SNP	tmVar:rs580382;VariantGroup:0;CorrespondingGene:84623;RS#:580382;CorrespondingSpecies:9606
36711847	1272	1279	KIRREL3	Gene	84623
36711847	1280	1289	rs4144611	SNP	tmVar:rs4144611;VariantGroup:1;CorrespondingGene:84623;RS#:4144611;CorrespondingSpecies:9606
36711847	1347	1353	EXOC6B	Gene	23233
36711847	1354	1364	rs61619102	SNP	tmVar:rs61619102;VariantGroup:2;CorrespondingGene:23233;RS#:61619102;CorrespondingSpecies:9606
36711847	1531	1538	KIRREL3	Gene	84623
36711847	1567	1573	EXOC6B	Gene	23233
36711847	1628	1632	CD34	Gene	947
36711847	1633	1638	CD133	Gene	8842
36711847	1700	1702	AD	Disease	MESH:D000544
36711847	1768	1775	KIRREL3	Gene	84623
36711847	1780	1786	EXOC6B	Gene	23233
36711847	Association	MESH:D000544	23233
36711847	Association	MESH:D000544	RS#:4144611;CorrespondingGene:84623
36711847	Association	MESH:D000544	RS#:61619102;CorrespondingGene:23233
36711847	Association	MESH:D000544	84623
36711847	Positive_Correlation	MESH:D000544	RS#:580382;CorrespondingGene:84623
36711847	Negative_Correlation	MESH:D000544	8842
36711847	Negative_Correlation	MESH:D000544	947
36711847	Association	MESH:D000544	84623
36711847	Association	MESH:D000544	23233

